SCHEMBL1376342

SCHEMBL1376342

O=Cc1cccnc1Nc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 4/20 0.56
KMT2A Q03164 7/20 0.51
MEN1 O00255 6/20 0.51
ALDH1A1 P00352 3/20 0.51
MAPT P10636 3/20 0.51
GAA P10253 1/20 0.51
TRIM24 O15164 1/20 0.47
TRIM33 Q9UPN9 1/20 0.47
GRM4 Q14833 1/20 0.45
RAB9A P51151 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CLK1 P49759 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
NPSR1 Q6W5P4 2/20 0.42
MAPK1 P28482 1/20 0.42
BLM P54132 2/20 0.41
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6644285 0.85 MAP4K4 (0.43) DHODHKMT2AMAPTTRIM24TRIM33
SCHEMBL10835241 0.85 RAB9A (0.56) DHODHKMT2AMEN1ALDH1A1MAPT
SCHEMBL16627428 0.85 MEN1 (0.49) DHODHKMT2AMEN1ALDH1A1MAPT
SCHEMBL9402324 0.85 DHODH (0.57) DHODHKMT2AMEN1MAPTTRIM24
SCHEMBL9402383 0.85 RAB9A (0.57) DHODHKMT2AMEN1ALDH1A1MAPT
SCHEMBL8835483 0.81 RAB9A (0.60) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL10674155 0.81 LMNA (0.59) DHODHKMT2AMEN1ALDH1A1GRM4
SCHEMBL6643061 0.81 NPC1 (0.59) KMT2AMEN1ALDH1A1MAPTGRM4
SCHEMBL10677709 0.81 ABCG2 (0.47) DHODHALDH1A1TRIM24TRIM33RAB9A
SCHEMBL9402355 0.81 GRM4 (0.52) KMT2AMEN1GRM4RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2846803-A1 ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATORS, THEIR DERIVATIVES AND USES THEREOF Anvyl, LLC (US) 2015-03-18 EP claimed
WO-2013169889-A1 ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATORS, THEIR DERIVATIVES AND USES THEREOF ANVYL LLC (US) 2013-11-14 WO claimed
CN-107573340-B Preparation and application of 2-carbamoyl-4-aryl hetero pyridine compound 江西科技师范大学 2020-11-24 CN disclosed
US-9006451-B1 2-anilinonicotinyl based chalcones useful as potential anticancer agents and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-14 US disclosed
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-09 US disclosed
EP-2846803-A1 ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATORS, THEIR DERIVATIVES AND USES THEREOF Anvyl, LLC (US) 2015-03-18 EP disclosed
EP-2394995-B1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES KUMIAI CHEMICAL INDUSTRY CO (JP) 2014-01-15 EP disclosed
WO-2013169889-A1 ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATORS, THEIR DERIVATIVES AND USES THEREOF ANVYL LLC (US) 2013-11-14 WO disclosed
US-8334236-B2 Ring-fused 2-pyridone derivatives and herbicides KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2012-12-18 US disclosed
EP-2394995-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES Kumiai Chemical Industry CO., LTD. (JP) 2011-12-14 EP disclosed
US-20110287937-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2011-11-24 US disclosed
US-5760034-A ANTIALLERGEN, ANTIINFLAMMATORY, ANTIULCER SCHERING CORPORATION (US) 1998-06-02 US disclosed
US-5364860-A Naphthyridine compounds which inhibit tyrosine kinase and their pharmaceutical compositions LABORATOIRES UPSA (FR) 1994-11-15 US disclosed
EP-0505434-A1 HETEROCYCLIC SUBSTITUTED NAPHTHYRIDINONES AND METHODS AND COMPOSITIONS EMPLOYING THEM SCHERING CORPORATION (US) 1992-09-30 EP disclosed
US-5037826-A Antiallergy, antiulcer, antiinflammatory, skin disorders, immune suppressants SCHERING CORPORATION (US) 1991-08-06 US disclosed
WO-1991008208-A1 HETEROCYCLIC SUBSTITUTED NAPHTHYRIDINONES AND METHODS AND COMPOSITIONS EMPLOYING THEM SCHERING CORPORATION (US) 1991-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287937-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES CBR3, CBR1, CHRM1 DHODH 780/4885KMT2A 2625/4885MEN1 4177/4885
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof HCCS, WEE2, WEE1 DHODH 637/4885KMT2A 2973/4885MEN1 2511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.